Amplification and over-expression of the MDM2 gene in human soft tissue tumours

Sarcoma

Volumn 1, Issue 1, 1997, Pages 17-22

  Patterson, Helen ^a   Barnes, Diana ^b   Gill, Sandra ^a   Spicer, James ^b   Fisher, Cyril ^c   Thomas, Merion ^c   Grimer, Robert ^d   Fletcher, Chris ^e   Gusterson, Barry ^a   Cooper, Colin ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Amplification; MDM2 gene; Over expression; Soft tissue sarcoma

Indexed keywords

EID: 0007267495     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13577149778434     Document Type: Article

References (28)

1. Mandahl N, Heim S, Willen H, et al. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chrom Cancer 1989; 1:9-14.
2. Mertens F, Johansson B, Mandahl N, et al. Clonal chromosome abnormalities in two liposarcomas. Cancer Genet Cytogenet 1987; 28:137-44.
3. Wang-Wuu S, Soukop S, Ballard E, et al. Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res 1988; 48:983-7.
4. Oliner JD, Kinzler KW, Meltzer PS, et al. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358:80-3.
5. Kinzler KW, Ruppert JM, Bigner SH, et al. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature 1988; 332:371-4.
6. Khatib ZA, Matsushime H, Valentine M, et al. Coamplification of the CDK4 gene with the MDM2 and GLI in human sarcomas. Cancer Res 1993; 53:5535-41.
7. Forus A, Florenes VA, Maelandsmo GM, et al. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Diff 1993; 4:1065-70.
8. Jankowski SA, Mitchell DS, Smith SH, et al. SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 1994; 9:1205-11.
9. Fakharzedeh SS, Trusko SP, George DL. Tumourigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line. EMBO J 1991; 10:1565-9.
10. Momand J, Zambetti GP, Olsen DC, et al. The MDM2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237-45.
11. Wu X, Bayle JH, Olsen D, et al. The p53-MDM2 auto-regulatory feedback loop. Genes Dev 1993; 7: 1126-32.
12. Xiao Z-X, Chen J, Levine AJ, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995; 375:694-8.
13. Martin K, Trouche D, Hagemeier C, et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 1995; 375:691-4.
14. Cordon-Cardo C, Latres E, Drobnjak M, et al. Molecular abnormalities of MDM2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994; 54:794-9.
15. Leach FS, Tokino T, Meltzer P, et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993; 53:2231-4.
16. Florenes VA, Maelandsmo GM, Forus A, et al. MDM2 gene amplification and transcript levels in human sarcomas: relationship to p53 gene status. J Natl Cancer Inst 1994; 86:1297-1302.
17. Nakayama T, Toguchida, Wadayama BI, et al. MD-M2 gene amplification in bone and soft tissue tumours: association with tumour progression in differentiated adipose-tissue tumours. Int J Cancer 1995; 64:342-6.
18. Lianes P, Orlow I, Zhang ZF, et al. Altered patterns of MDM2 and p53 expression in human blader cancer. J Natl Cancer Inst 1994; 86: 1325-30.
19. Bueso Ramos CE, Yang Y, deLeon E, et al. The human MDM2 gene is over-expressed in leukaemias. Blood 1993; 82:2617-23.
20. Garvin AJ, Stanley WS, Bennett DD, et al. The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. Am J Pathol 1986; 125:208-17.
21. Steffen D, Weinberg RA. The integrated genome of murine leukaemia virus. Cell 1978; 15:1003-10.
22. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci 1984; 81:1991-5.
23. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132:6-13.
24. Patterson H, Gill S, Fisher C, et al. Abnormalities of the p53, MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer 1994; 69:1052-8.
25. Pickersley SM, Vojtesek B, Sparks A, et al. Immunohistochemical analysis of the interaction of p53 with MDM2; fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 1994; 9:2523-9.
26. Ladanyi M, Cha C, Lewis R, et al. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993; 53:16-18.
27. Landers JE, Haines DS, Strauss JF III, et al. Enhanced translation: a novel mechanism of MDM2 oncogene over-expression identified in human tumour cells. Oncogene 1994; 9:2745-50.
28. Stratton MR, Moss S, Warren W, et al. Mutation of the p53 gene in human soft tissue sarcomas: associ-ation with abnormalities of the Rl gene. Oncogene 1990; 5:1297-301.